Mumbai, February 21, 2020: The coronavirus continues to spread. Authorities around the world are therefore tightening measures to stop the further spread of the lung disease. With no vaccine available, disinfection is of the utmost importance.
The high level disinfectant Rely+On Virkon from specialty chemicals company LANXESS is effective against the coronavirus. The product is used for hard surface and equipment disinfection. Anneliese Bischof, Head of the Disinfectants Business at LANXESS: “Following the outbreak of the coronavirus, we are seeing increased demand for Rely+On Virkon in China and other countries around the globe. We are therefore currently working intensively to optimally align our production and logistics capacities to deliver additional product quantity to this region as quickly as possible.”
Rely+On Virkon inactivates coronavirus quickly
Independent tests have proven that Rely+On Virkon inactivates a closely related surrogate of the currently spreading coronavirus strain. “From these tests it can be concluded that Rely+On Virkon is also effective against 2019-nCoV,” Bischof said.
In independent tests Rely+On Virkon achieved inactivation of the coronavirus strain at a 1:100 dilution rate with a 10-minute contact time. This corresponds to test conditions required by the U.S. Environmental Protection Agency (EPA) and proves the performance and suitability of Rely+On Virkon for practical use.
Rely+On Virkon is diluted for application and sprayed on hard surfaces and equipment. It can therefore help to reduce the risk of contamination of surfaces, door handles, tables or chairs during disinfection measures at public transport terminals, airports, hospitals, clinics, shopping malls, etc.
LANXESS produces a wide range of scientifically based biocide technologies under the Virkon brand. Virkon is manufactured by the LANXESS Material Protection Products business unit. The business unit belongs to LANXESS’s Performance Chemicals segment, with sales of 1.35 billion euros in 2018.
LANXESS is a leading specialty chemicals company with sales of EUR 7.2 billion in 2018. The company currently has about 15,500 employees in 33 countries and is represented at 58 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.
Corporate Comm India (CCI Newswire)
By Dr. Sandhya Rani, Sr. Consultant - Obstetrics & Gynaecology, Aster Women & Children Hospital,…
Coimbatore, December 28, 2024: Sri Ramakrishna Hospital took a proactive approach to combat the rising…
The 22-Year-Old Founder of Generic Aadhaar Distributes Free Cancer Medicines to 87 Patients, Advancing Shri…
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as…
Previously, the patient underwent an above-knee amputation in the USA due to similar complications in the…
New Delhi, December 27, 2024: A team of expert obstetricians & neonatologists at Motherhood Hospitals,…